In this episode of Tush Talks, Patil Mksyartinian, a Program Manager at Colorectal Cancer Canada, answers frequently asked questions about circulating tumour DNA (ctDNA) for colorectal cancer (CRC). She discusses the role of ctDNA testing, how it can detect molecular residual disease (MRD), and options for accessing ctDNA testing.
For more information about ctDNA and ctDNA testing, please contact us at info@colorectalcancercanada.com OR If you have any additional questions about ctDNA, please contact us at info@colorectalcancercanada.com.
Categories:
After Treatment, In Treatment
